ISPOR in Montreal
Meet us at ISPOR 2025 (Booth 901)
We’re proud to attend and present at ISPOR North America
May 14th at 4:00pm: Beyond Clinical Data: Assessing Usage Patterns of Real-World Home-Reported Outcomes To Capture the Full Burden of Atopic Dermatitis Symptoms and Flares
May 14th at 4:00pm: Exploring Patterns of App-Based Tracking of Real-World Symptom and Treatment Experiences in Patients with Sickle Cell Disease and Cystic Fibrosis
May 15th at 10:30am: Tracking Patterns in Sleep Disturbances during Flare-Ups in Patients with Atopic Dermatitis: Insights from an App-Based Digital Health Tracking Study
Why Life Sciences Leaders Choose Folia
Folia Health partners with leading research organization to solve evidence generation gaps:
“This is exactly what we need as part of our go-to-market strategy. We need patients to be able to see they’re doing better on a new treatment than they were before.”
“The relative benefit of Folia to a drug increases as you start early. This is true disseminated data capture; decentralized trials are a tactical component of that overall strategy. You’re adding to, not taking away from, claims & clinical data. Pharma would prefer a single source of truth, and you’re moving us in that direction.”
“This is important. Clinical trials use narrowly defined populations that are supposed to be representative. But the inclusion criteria are very specific. They therefore don’t get a good grasp of comorbidities or which patients may respond to treatment best.”